Less Ads, More Data, More Tools Register for FREE

Pin to quick picksInvestacc Group Regulatory News (INAC)

Share Price Information for Investacc Group (INAC)

Share Price is delayed by 15 minutes
Get Live Data
168.00    0.00 (0.00%)
Bid:
166.00
Ask:
170.00
Spread: 4.00 (2.41%)
Market Cap: £83.03m
INAC Live PriceLast checked at - London Stock Exchange

Intraday Investacc Group Share Chart

Total Voting Rights

28 Nov 2025 07:00

RNS Number : 0615I
Investacc Group Limited
28 November 2025
 

THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED HEREIN IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, THE REPUBLIC OF SOUTH AFRICA, JAPAN, ANY MEMBER STATE OF THE EUROPEAN ECONOMIC AREA OR ANY JURISDICTION IN WHICH IT WOULD BE UNLAWFUL TO DO SO.

LEI: 2549008KZ7HM27V4O637

28 November 2025

InvestAcc Group Limited (the "Company" or "InvestAcc")

Total Voting Rights

In accordance with the requirements of the Financial Conduct Authority's Disclosure and Transparency Rules ("DTRs") 5.6.1, the Company is notifying the market that as at 28 November 2025 it has in issue 49,420,712 ordinary shares of no par value and carrying one vote each. The Company does not hold any ordinary shares in treasury and has in issue one sponsor share which does not carry the right to vote at meetings of Shareholders. Accordingly, the total number of voting rights in the Company is 49,420,712 which should be used by shareholders as the denominator for the calculations by which they will determine to notify their interest in, or a change to, their interest in the Company under the DTRs.

Enquiries:

Company Secretary: + 44 (0) 207 004 2700 Antoinette Vanderpuije

Camarco (PR Adviser): + 44 (0) 203 757 4980 Ed Gascoigne-Pees / Phoebe Pugh

KK Advisory (IR Adviser): + 44 (0) 207 039 1901 Kam Bansil

Panmure Liberum Limited (Corporate Broker): + 44 (0) 203 100 2000 Chris Clarke / Ed Thomas

Zeus Capital Limited (Corporate Broker): + 44 (0) 207 220 1666Harry Ansell / Katy Mitchell

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TVREAXFPFDESFFA
Date   Source Headline
26th Mar 202611:21 amRNSResult of AGM
19th Mar 20267:00 amRNSFull Year Results to 31 December 2025
2nd Mar 20267:00 amRNSNotice of AGM
26th Feb 20267:00 amRNSNotice of Results
9th Jan 20267:00 amRNSDirectorate change
28th Nov 20257:00 amRNSTotal Voting Rights
3rd Nov 20257:00 amRNSCompletion of Acquisition
31st Oct 20257:00 amRNSIssuance of shares and total voting rights
25th Sep 20257:00 amRNSInterim results: six months ended 30 June 2025
24th Apr 20257:00 amRNSFinal Results 2024 and Q1 2025 Trading Update
27th Mar 20257:00 amRNSAcquisition and Announcement of Results Date
20th Feb 20254:15 pmRNSUpdate on CFO appointment
20th Dec 20247:00 amRNSBoard Changes
5th Dec 20247:00 amRNSTrading Update and Change in Financial Year End
31st Oct 20247:00 amRNSTotal Voting Rights
17th Oct 20245:00 pmRNSHolding(s) in Company
16th Oct 20247:00 amRNSAppointment of Independent Non-Executive Directors
14th Oct 202412:00 pmRNSHolding(s) in Company
14th Oct 202412:00 pmRNSHolding(s) in Company
9th Oct 20248:00 amRNSReadmission - Marwyn Acquisition Company II Ltd
9th Oct 20248:00 amRNSCompletion of the InvestAcc Acquisition

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.